MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS

Multiple-variable dose methods for treating TNFα-related disorders, including Crohn's disease and psoriasis, comprising administering TNFα inhibitors, including TNFα antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading ph...

Full description

Saved in:
Bibliographic Details
Main Authors Taylor Lori K, Hoffman Rebecca S, Peng Joanna Z, Granneman George Richard, Paulson Susan K, Chartash Elliot Keith, Yan Philip
Format Patent
LanguageEnglish
Published 16.02.2017
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Multiple-variable dose methods for treating TNFα-related disorders, including Crohn's disease and psoriasis, comprising administering TNFα inhibitors, including TNFα antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF-inhibitor is administered in a higher dosage during the induction phase.
AbstractList Multiple-variable dose methods for treating TNFα-related disorders, including Crohn's disease and psoriasis, comprising administering TNFα inhibitors, including TNFα antibodies, are described. Multiple-variable dose methods include administration of a TNF-inhibitor in an induction or loading phase followed by administration of the agent in a maintenance or treatment phase, wherein the TNF-inhibitor is administered in a higher dosage during the induction phase.
Author Yan Philip
Chartash Elliot Keith
Peng Joanna Z
Hoffman Rebecca S
Granneman George Richard
Paulson Susan K
Taylor Lori K
Author_xml – fullname: Taylor Lori K
– fullname: Hoffman Rebecca S
– fullname: Peng Joanna Z
– fullname: Granneman George Richard
– fullname: Paulson Susan K
– fullname: Chartash Elliot Keith
– fullname: Yan Philip
BookMark eNqNyrsKwjAUANAMOvj6h4BzoK0BcYzmpgbSpNykriVIxKGkgfr_uPgBTmc5W7LKc04borrBBN0bYA-BWlwNUOk8UIRWd2CpckgDggjatjRYFafyjgzBiACSSu0dSkC_J-tXnJZ0-LkjRwXhdmepzGNaSnymnD7j4JuqPlecN_wi6tN_6wvdey_C
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2017044249A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2017044249A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:57:33 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2017044249A13
Notes Application Number: US201514745092
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170216&DB=EPODOC&CC=US&NR=2017044249A1
ParticipantIDs epo_espacenet_US2017044249A1
PublicationCentury 2000
PublicationDate 20170216
PublicationDateYYYYMMDD 2017-02-16
PublicationDate_xml – month: 02
  year: 2017
  text: 20170216
  day: 16
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies AbbVie Biotechnology Ltd
RelatedCompanies_xml – name: AbbVie Biotechnology Ltd
Score 3.081234
Snippet Multiple-variable dose methods for treating TNFα-related disorders, including Crohn's disease and psoriasis, comprising administering TNFα inhibitors,...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170216&DB=EPODOC&locale=&CC=US&NR=2017044249A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt-K6tR0-DOnadKu03ejH2NtI2g4G0g1X8d_3Ejvd096SHByXwOWXX3J3AXjOmPGaIYyoS22ZIUHpFCordKZ2-wi-Rq_DDBntHoTmONXf58a8AR-7XBhZJ_RbFkdEj8rQ3yu5X2_-L7EcGVu5feErHFq_ucnAUWp2rPURskzFGQ7odOJMbMW2B2mshNGvTNeRbFjIlY7EQVpU2qezochL2eyDinsOx1PUV1YX0CjKFpzau7_XWnAS1E_e2Ky9b3sJbpD6iTf1qTqzIs8a-pQ4k5iSiI68gIYECR1JImolXjgiSejKPFpVfIqB2xNxvBgJH43iK3hyaWKPVTRo8Tf_RRrvW9-7hma5LosbILxf5OJhjbOc6abGOEcyw7s4mHeYrrFbaB_SdHdYfA9noitClDWzDc3q86t4QASu-KNcuB8weIQl
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfZ3fS8MwEMePMcX5plPxx9SA0rfiuvUHPgzp2nSrtt1o07G3kXQdCNINV_Hf9xo33dPeQg5CErh8-SR3OYDHjBvPGcqIutAWGQJKO1d5rnO1Y6H4Gt02N2S0exiZw1R_nRrTGnxsc2HkP6Hf8nNE9KgM_b2U5_Xq_xLLlbGV6yfxjl3LF4_1XGVDx5qFkmUqbr9HxyN35CiO00sTJYp_bbqOsGEjKx1YCIUSlib9Ki9ltSsq3gkcjnG8ojyFWl40oeFsa6814SjcPHljc-N96zPwwjRg_jig6sSOfbsfUOKOEkpiOvBDGhEEOsJiajM_GhAWeTKPVq2KYuDxRFw_QeCjcXIODx5lzlDFCc3-1j9Lk93Zdy-gXiyL_BKIsPJ59bAm-JzrpsaFQJgRHeyct7mu8Sto7Rvper_5HhpDFgazwI_ebuC4MlXhyprZgnr5-ZXfohqX4k5u4g-DRocP
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MULTIPLE-VARIABLE+DOSE+REGIMEN+FOR+TREATING+TNFalpha-RELATED+DISORDERS&rft.inventor=Taylor+Lori+K&rft.inventor=Hoffman+Rebecca+S&rft.inventor=Peng+Joanna+Z&rft.inventor=Granneman+George+Richard&rft.inventor=Paulson+Susan+K&rft.inventor=Chartash+Elliot+Keith&rft.inventor=Yan+Philip&rft.date=2017-02-16&rft.externalDBID=A1&rft.externalDocID=US2017044249A1